Accelrys
 |
|
| Type | Public |
|---|---|
| Traded as | NASDAQ: ACCL |
| Industry | Life sciences, Materials science |
| Founded | 2001 |
| Headquarters | San Diego, California, USA Cambridge, UK Tokyo, Japan |
| Key people | Max Carnecchia, President and CEO Michael A. Piraino, CFO David Mersten,Senior Vice President, General Counsel and Secretary Frank Brown Chief Science Officer |
| Revenue | US$81 Million |
| Employees | 700+ |
| Website | www.accelrys.com |
Accelrys (NASDAQ: ACCL) is a software company headquartered in the US, with representation in Europe and Japan. It provides software for chemical, materials and bioscience research for the pharmaceutical, biotechnology, consumer packaged goods, aerospace, energy and chemical industries.
Accelrys started in 2001 from the fusion of five companies: Molecular Simulations Inc. (MSI, itself a result of the combination of Biodesign, Cambridge Molecular Design, Polygen and, later, Biocad and Biosym Technologies), Synopsys Scientific Systems, Oxford Molecular, the Genetics Computer Group (GCG), and Synomics Ltd. In 2004, Accelrys acquired SciTegic, producer of the Pipeline Pilot software.[1] In 2010 Symyx Technologies was merged with Accelrys. In May 2011 the company acquired Contur Software AB, an electronic lab notebook software firm.
Accelrys manages a Nanotechnology Consortium producing software tools for rational nanodesign.[2]
[edit] Products
- Pipeline Pilot, a program that aggregates and provides immediate access to the volumes of disparate research data locked in silos, automates the scientific analysis of that data, and enables researchers to rapidly explore, visualize and report research results.
- Symyx Notebook by Accelrys, an electronic laboratory notebook.
- Materials Studio, a suite of modeling and simulation programs for material science.
- Discovery Studio, a suite of modeling and simulation programs for life sciences.
Commercial versions of otherwise academically licensed programs:
